Tuberculosis Testing Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Tuberculosis Testing Market by test type (culture based tests, nucleic acid testing (NAT); smear microscopy, IGRA, mantoux test, chest x-ray, xpert test, serological tests), end-user (hospitals, academics, research, reference, physician’s office laboratories) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Tuberculosis Testing Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Tuberculosis Testing Market are Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific Inc., bioMérieux SA, Siemens Healthineer Inc. According to report the global tuberculosis testing market is projected to grow at a CAGR of 12.5% over the forecast period of 2017-2023.
Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment’s and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
Coupled with high prevalence and incidences of TB are the major factors responsible for high growth of tuberculosis testing market. In addition, availability of new improved tests, increasing awareness level, developing infrastructure and increased involvement of some of the world’s leading organizations such as WHO (World Health Organization) and FIND (Foundation for Innovative New Diagnostics) contributing to the global growth of this market. On the other hand, High cost associated with testing procedures, lack of specificity and requirement of specialized equipment’s are the prime challenges of this market that are likely to limit the global growth over the forecast period. Rising prevalence of TB, numerous tuberculosis awareness and control program launched by the government organizations and great market potential due to developing economies expected to bring new growth opportunities in near future.
The report on global tuberculosis testing market covers segments such as, test type and end-user. On the basis of test type the global tuberculosis testing market is categorized into culture based tests, nucleic acid testing (NAT); smear microscopy, IGRA (interferon-gamma release assays), mantoux test (TST), chest x-ray, xpert test, serological tests, and other. On the basis of end-user the global tuberculosis testing market is categorized into hospitals laboratories, academics and research, reference laboratories, physician’s office laboratories and others
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global tuberculosis testing market such as, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., LIONEX Diagnostics & Therapeutics GmbH., Becton,bioMérieux SA, Hain Lifescience GmbH, Hologic Inc., QIAGEN, Abbott Laboratories, Alere Inc.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global tuberculosis testing market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of tuberculosis testing market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the tuberculosis testing market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the tuberculosis testing market to understand the present and future trends in this market and formulate their strategies accordingly.
Table of Contents:-
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Tuberculosis Testing Market Overview
3.2. Market Dynamics
3.3. Porter’s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Tuberculosis Testing Market
4. Global Tuberculosis Testing Market by Test Type
4.1. Culture Based Tests
4.2. Nucleic Acid Testing (NAT)
4.3. Smear Microscopy
4.4. IGRA (Interferon-Gamma Release Assays)
4.5. Mantoux Test (TST)
4.6. Chest X-Ray
4.7. Xpert Test
5. Global Tuberculosis Testing Market by End-User
5.1. Hospitals Laboratories
5.2. Academics and Research
5.3. Reference Laboratories
5.4. Physician’s Office Laboratories
6. Global Tuberculosis Testing Market by Region 2017-2023
6.1. North America
6.1.1. North America Tuberculosis Testing Market by Test Type
6.1.2. North America Tuberculosis Testing Market by End-User
6.1.3. North America Tuberculosis Testing Market by Country
6.2.1. Europe Tuberculosis Testing Market by Source Type
6.2.2. Europe Tuberculosis Testing Market by End-User
6.2.3. Europe Tuberculosis Testing Market by Country
6.3.1. Asia-Pacific Tuberculosis Testing Market by Test Type
6.3.2. Asia-Pacific Tuberculosis Testing Market by End-User
6.3.3. Asia-Pacific Tuberculosis Testing Market by Country
6.4.1. RoW Tuberculosis Testing Market by Test Type
6.4.2. RoW Tuberculosis Testing Market by End-User
6.4.3. RoW Tuberculosis Testing Market by Sub-region
7. Company Covered
7.1. F. Hoffmann-La Roche Ltd.
7.2. Danaher Corporation
7.3. Thermo Fisher Scientific Inc.
7.4. LIONEX Diagnostics & Therapeutics GmbH.
7.5. Becton,bioMérieux SA
7.6. Hain Lifescience GmbH
7.7. Hologic Inc.
7.9. Abbott Laboratories
7.10. Alere Inc
Browse Detailed TOC, Description and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_tuberculosis_testing_market